CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE1971.6035.6 (+1.84 %)
PREV CLOSE () 1936.00
OPEN PRICE () 1947.05
BID PRICE (QTY) 1971.60 (30)
OFFER PRICE (QTY) 1972.70 (18)
VOLUME 54302
TODAY'S LOW / HIGH ()1917.10 1973.90
52 WK LOW / HIGH ()822.85 1981
NSE1970.2025.2 (+1.3 %)
PREV CLOSE() 1945.00
OPEN PRICE () 1943.00
BID PRICE (QTY) 1970.50 (19)
OFFER PRICE (QTY) 1971.00 (249)
VOLUME 2091696
TODAY'S LOW / HIGH() 1918.10 1981.80
52 WK LOW / HIGH ()823.1 1955
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2005

Management Info :

Ravindranath Kancherla - Chairman - Managing Director

Registered Office :

Address : Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli,
Vishakhapatnam,
Andhra Pradesh-531021

Phone : 0891 6821101 / 1102

Website : www.lauruslabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
31Aug Laurus Labs submits analyst meet intim
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
08Jun Laurus Labs informs about AGM
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosur..
08May Laurus Labs informs about newspaper a
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
02May Laurus Labs informs about press release
Laurus Labs has informed that it enclosed copies of the newspaper advert..
20Feb Laurus Labs informs about disclosure
Laurus Labs has informed that it enclosed disclosure under Regulation 29..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit2899.67404.80000000001
Gross Profit 3881.7 9940.90000000001
Operating Profit 5191.315156.9
Net Sales 17571.660890.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25560.75 (1.14%)
M.Cap ( in Cr)
54249.47
Onesource Specialty (BSE)
 1601.30 (3.61%)
M.Cap ( in Cr)
18389.52
SMS Pharmaceuticals (BSE)
 462.10 (10.25%)
M.Cap ( in Cr)
4336.09
Torrent Pharma (BSE)
 4968.90 (0.82%)
M.Cap ( in Cr)
189012.40
Rubicon Research (BSE)
 1828.70 (2.13%)
M.Cap ( in Cr)
29605.38
Shareholding Pattern
NON-INSTITUTION 30.79%
PROMOTERS 27.47%
MUTUAL FUNDS/UTI 10.15%
FI/BANKS/INSURANCE 2.33%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74858.22-44.37 (-0.06%)
NIFTY23396.55-81.25 (-0.35%)
Dow Jones 52064.10-316.56 (-0.60%)
Nasdaq 26081.72-171.62 (-0.65%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI